drugset / Trial / NCT01044277

Oral Glutathione Supplementation on the Levels of Blood Glutathione

NCT01044277

Completed 61 enrolled Milton S. Hershey Medical Center
RandomizedParallel-groupDouble-blindBasic science

Summary

This trial is designed to provide evidence of the efficacy of glutathione supplementation and health(GSH) and includes the assessment of both short term and long term effects. Based on previous laboratory animal studies and clinical data, the investigators anticipate that the effects of oral GSH supplementation will be progressive and cumulative. The study will also allow for the evaluation of effects of withdrawal of the supplement on the outcome variables.

Timeline

Start
2010-02
Primary completion
2011-09
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutathione Peptide 125 mg Oral
Subject Glutathione Peptide 500 mg Oral

Indications

No indication recorded.